<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00462020</url>
  </required_header>
  <id_info>
    <org_study_id>07 02 031</org_study_id>
    <nct_id>NCT00462020</nct_id>
  </id_info>
  <brief_title>Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis</brief_title>
  <official_title>Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Mercy Hospital Kansas City</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Mercy Hospital Kansas City</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to scientifically evaluate two different management strategies&#xD;
      for perforated appendicitis.&#xD;
&#xD;
      The hypothesis is that early discharge with oral antibiotic therapy may result in a dramatic&#xD;
      decrease in medical care expenses for the patient.&#xD;
&#xD;
      The primary outcome variable between the two strategies is abscess rate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a single institution, prospective, randomized clinical trial involving patients&#xD;
      who present to the hospital with perforated appendicitis. This will be a definitive study.&#xD;
&#xD;
      Power calculation was based on abscess rate in the previous prospective, randomized study we&#xD;
      just finished. Our current rate is 18%, or just under one-fifth of the patients. A doubling&#xD;
      of this rate to 36% would place just over one third of the patients at risk which would be&#xD;
      unacceptable. Using a delta of 0.18 with alpha of 0.05 and power of 0.8, the sample size is&#xD;
      74 patients in each arm. Therefore we will anticipate enrolling 150.&#xD;
&#xD;
      Subjects will be those children who undergo a laparoscopic appendectomy as part of their&#xD;
      routine care.&#xD;
&#xD;
      Perforation will be defined as an identifiable hole in the appendix or stool in the abdomen.&#xD;
&#xD;
      The control group will receive current standard care: ceftriaxone 50mg/kg once a day (maximum&#xD;
      dose = 2 grams) and metronidazole 30mg/kg once a day (maximum dose = 1 gram) with once a day&#xD;
      dosing for both. The length of antibiotic therapy will be a minimum of 5 days. At that time,&#xD;
      if they have been afebrile for at least 24 hours, a white blood cell (WBC) count will be&#xD;
      obtained, and if that is within normal limits, the antibiotics will be discontinued and the&#xD;
      patient will be discharged. If the WBC is elevated, they will receive another 2 days before&#xD;
      recheck, if still elevated, they receive another 3 days and a CT Scan is obtained. If, after&#xD;
      5 days of therapy, the patient remains febrile, therapy will continue until afebrile before a&#xD;
      WBC check is performed. This is all our current standard management.&#xD;
&#xD;
      The experimental group will receive the same combination of antibiotics while in the&#xD;
      hospital. When the patient is tolerating a regular diet, on oral pain medication and has been&#xD;
      afebrile for over 12 hours, they will be discharged on oral antibiotics to complete a course&#xD;
      of 7 days. The home antibiotic regimen will be ampicillin/clavulanic acid (Augmentin®).&#xD;
      Augmentin® dose will be 40mg/kg twice a day. They will be asked to bring their pill&#xD;
      containers with them to clinic where we will quantify medication compliance.&#xD;
&#xD;
      Given the purpose of this study is the comparison of oral antibiotics to intravenous&#xD;
      antibiotics, an allergy to one of the above medications will not be considered an exclusion&#xD;
      criteria. In such cases the patient will be treated with an alternative that offers the same&#xD;
      spectrum of coverage, but will be included in the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Abscess After Appendectomy</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative Time</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Regular Diet</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay After Operation</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Healthcare Visits</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Perforated Appendicitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 days of IV antibiotics after appendectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5 days of IV antibiotics (ceftriaxone and metronidazole)</intervention_name>
    <description>5 days of IV antibiotics (ceftriaxone and metronidazole once a day dosing)</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Home with oral antibiotics when eating (ampicillin/clavulanic acid)</intervention_name>
    <description>Augmentin 40mg/kg BID when tolerating POs to complete 7 days total</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Identifiable hole in the appendix or stool in the abdomen at the time of appendectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known immune deficiency&#xD;
&#xD;
          -  Abscess identified on pre-op imaging&#xD;
&#xD;
          -  Another condition affecting surgical decision making or recovery (e.g. hemophilia,&#xD;
             severe cardiac or respiratory co-morbidities).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shawn D St. Peter</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Mercy Hospital Kansas City</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>April 16, 2007</study_first_submitted>
  <study_first_submitted_qc>April 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2007</study_first_posted>
  <results_first_submitted>December 12, 2011</results_first_submitted>
  <results_first_submitted_qc>December 12, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 13, 2011</results_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>appendicitis, perforation, abscess, treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Ceftriaxone</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Ampicillin</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>All patients with perforated appendicitis were recruited for this study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>IV Only</title>
          <description>5 days of IV antibiotics after appendectomy</description>
        </group>
        <group group_id="P2">
          <title>IV and Oral Abx</title>
          <description>home on oral antibiotics to complete 7 days of treatment</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IV Only</title>
          <description>5 days of IV antibiotics after appendectomy</description>
        </group>
        <group group_id="B2">
          <title>IV and Oral Abx</title>
          <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="52"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.7" spread="4.2"/>
                    <measurement group_id="B2" value="10.1" spread="4.6"/>
                    <measurement group_id="B3" value="9.9" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Abscess After Appendectomy</title>
        <time_frame>1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Only</title>
            <description>5 days of IV antibiotics after appendectomy</description>
          </group>
          <group group_id="O2">
            <title>IV and Oral Abx</title>
            <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
          </group>
        </group_list>
        <measure>
          <title>Abscess After Appendectomy</title>
          <units>number of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operative Time</title>
        <time_frame>1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Only</title>
            <description>5 days of IV antibiotics after appendectomy</description>
          </group>
          <group group_id="O2">
            <title>IV and Oral Abx</title>
            <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
          </group>
        </group_list>
        <measure>
          <title>Operative Time</title>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.06" spread="15.36"/>
                    <measurement group_id="O2" value="46.30" spread="19.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Regular Diet</title>
        <time_frame>1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Only</title>
            <description>5 days of IV antibiotics after appendectomy</description>
          </group>
          <group group_id="O2">
            <title>IV and Oral Abx</title>
            <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Regular Diet</title>
          <units>Hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.00" spread="35.06"/>
                    <measurement group_id="O2" value="61.42" spread="32.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay After Operation</title>
        <time_frame>1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Only</title>
            <description>5 days of IV antibiotics after appendectomy</description>
          </group>
          <group group_id="O2">
            <title>IV and Oral Abx</title>
            <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay After Operation</title>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.06" spread="2.00"/>
                    <measurement group_id="O2" value="4.48" spread="2.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Healthcare Visits</title>
        <time_frame>1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Only</title>
            <description>5 days of IV antibiotics after appendectomy</description>
          </group>
          <group group_id="O2">
            <title>IV and Oral Abx</title>
            <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
          </group>
        </group_list>
        <measure>
          <title>Total Healthcare Visits</title>
          <units>Visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1.4"/>
                    <measurement group_id="O2" value="3.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 month</time_frame>
      <desc>No Adverse Events were recorded</desc>
      <group_list>
        <group group_id="E1">
          <title>IV Only</title>
          <description>5 days of IV antibiotics after appendectomy</description>
        </group>
        <group group_id="E2">
          <title>IV and Oral Abx</title>
          <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Shawn D. St. Peter, MD</name_or_title>
      <organization>Children's Mercy Hospital</organization>
      <phone>816-983-6479</phone>
      <email>sspeter@cmh.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

